FREMONT, Calif., July 27, 2016 /PRNewswire/ -- Through its integrated solution for clinical trial management (Velos eResearch) and bio-specimen management (Velos eSample), Velos is helping facilitate translational and clinical research at BloodCenter of Wisconsin (BCW). As a result of the new implementation, study administration, study execution, patient management, and bio-specimen management are available to BCW researchers in one integrated system. The Velos platform is currently supporting 6,800 research participants across multiple studies and over 200,000 bio-specimen records.
A premier center that specializes in blood services and treatment of blood-related diseases, BloodCenter of Wisconsin regularly conducts studies of bleeding and clotting disorders, coagulation, and more. "We selected Velos as it offered comprehensive functionality and flexible technology to further our vision to span basic, translational and clinical research," said Dr. Thomas Abshire, Sr Vice President and Chief Medical Officer at BCW. "By leveraging the platform's integrated capabilities, we are able to expedite the research process, enhance data quality, improve data access, and integrate specimen, patient and research data. It is now possible for us to validate and support the clinical utility of a novel screening assay for diagnosing bleeding and clotting disorders more quickly."
"Our solution is designed to be scalable, configurable and interoperable, ensuring that it evolves as organizations grow and transform," said Priti Sahai, M.D., Sr Vice President of Velos. "BloodCenter of Wisconsin leverages the powerful protocol design and comprehensive study management capabilities of Velos eResearch to define protocol-based sample acquisition workflows. With a few clicks, users can assay results collection, analyze and query longitudinal data, create and manage biomedical repositories, and ensure protocol and participant compliance."
"BloodCenter of Wisconsin gave us a tremendous opportunity to help them improve clinical and translational research efforts so that they can save and enhance more patients' lives," said John McIlwain, CEO of Velos. "We are proud of developing an integrated and efficient clinical research information ecosystem that adapts to BloodCenter of Wisconsin's business, technical, and functional needs."
Velos is the trusted clinical trial management resource for investigators, sponsors, and academic leaders throughout the world. Velos integrates the clinical, administrative and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California. For more information, visit www.velos.com